Global capabilities
Delivering value beyond the test result
At Mayo Clinic Laboratories, laboratory medicine is about more than a test result — it’s about everything that contributes to providing answers for your patients. We develop individualized support solutions for each client that extend through all aspects of the relationship to ensure the delivery of answers, not just results.
Specialized testing areas include:
Global logistics and shipping
We develop unique relationships with each client to individualize logistics support, which is coordinated by a local team who ensures a seamless process before the first patient specimen is sent. Our specialists collaborate with packaging suppliers to create unique solutions that extend the stability of specimens traveling around the world.
These experts ensure specimens are handled carefully and efficiently through close connections to shipping carriers. The air carriers we work with are experienced with processing clinical specimens.
Optimized, expeditious processing
We recognize many medical conditions have a window of opportunity for the best possible outcomes. Our tests and processes are optimized to better serve patients and deliver results with outcomes in mind. We do not triage specimens across a network of labs or use a batch-testing business model. Result turnaround times are expedited by:
- Running tests continuously – your samples are processed alongside those from Mayo Clinic.
- A testing approach that incorporates comprehensive panels and algorithms when appropriate.
- Utilization of Lean and Six Sigma processes.
Reliable connectivity
We offer technology solutions to help our clients connect to us, including a secure online portal with interfacing capabilities that allows you to easily order tests and receive results. Our solutions include:
- Client-friendly test ordering through MayoLINK, which is available in eight languages.
- Expansive website with links to our open- access test catalog, which is updated daily and features comprehensive clinical information, including specimen requirements; clinical and interpretative information; performance; sample test reports; setup files; and pricing.
- 30 country-specific toll-free numbers.
News and updates
The latest
Dr. Bill Morice shares how clinical diagnostics are expanding to guide treatment and enable clinicians to target therapies more precisely.
This week's research roundup features Measurable residual disease does not preclude prolonged progression-free survival in CLL treated with Ibrutinib.
Topic's Include: Mayo Clinic to offer COVID-19 vaccination walk-in clinics in Rochester until August 28th, Mayo Clinic Q&A podcast: Breaking down the booster terminology for COVID-19 vaccines, and Mayo Clinic minute: Tips for a healthy school year.
Today's highlights include: U.S. to advise boosters for most Americans 8 months after vaccination , how does COVID-19 affect the brain, and Mayo Clinic announces $200 million project, expected to create over 100 new jobs.
In this episode of Lab Medicine Rounds, Matt Binnicker, Ph.D., Director of Clinical Virology and Vice Chair of Practice in the Department of Laboratory Medicine and Pathology at Mayo Clinic, provides an update on COVID-19 laboratory innovations including sequencing and diagnostics.
William Morice II, M.D., Ph.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and president of Mayo Clinic Laboratories, joins the "Answers From the Lab" podcast for his weekly leadership update. In this episode, Dr. Morice and Bobbi Pritt, M.D., explain COVID-19 vaccine boosters: what they are, how they work, and why they may be helpful in fighting the global pandemic.
This "Phlebotomy Webinar" presentation will review the methods available to detect latent infection with Mycobacterium tuberculosis, or latent tuberculosis infection (LTBI), including the classic tuberculin skin test and the more recently developed interferon gamma release assays (IGRA).
Dustin Strasburg’s role as a technical specialist in the Human Cell Therapy Lab gives him the opportunity to delve into a wide range of tasks — from research to experiment design to validation runs — all while staying laser-focused on meeting the needs of patients.
This week's research roundup features therapeutic anticoagulation with heparin in noncritically ill patients with COVID-19.
Topics include: Mayo Clinic Q&A podcast: How Mayo hopes to slam the door when COVID-19 comes knocking, what you need to know about COVID-19 tests, and Mayo Clinic preparing for COVID-19 vaccine boosters when approved.
In 1971, the Regional Laboratory, later to become Mayo Clinic Laboratories, was founded. For the first time in Mayo Clinic’s history, the institution would support the community practice of pathology for outside patients in the region and beyond.
Today's highlights include: FDA Covid-19 vaccine booster plan could be ready within weeks, how to tell if your child contracted Covid-19 or a common cold as school starts, and a Mayo Clinic expert discusses the delta variant.
In July 2021, Mayo Clinic Laboratories announced three new tests along with numerous reference value changes, obsolete tests, and algorithm changes.